Alnylam Pharmaceuticals
ALNY
#645
Rank
ยฃ25.09 B
Marketcap
ยฃ194.59
Share price
-0.77%
Change (1 day)
49.70%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company